Re: Employment OfferVascular Biogenics Ltd. • March 14th, 2023 • Pharmaceutical preparations
RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 14th, 2023 • Vascular Biogenics Ltd. • Pharmaceutical preparations
THIS RESTATED EMPLOYMENT AGREEMENT is made and entered into on January 20, 2022 (the “Effective Date”), by and between Vascular Biogenetics Ltd. (the “Company”) and Prof. Dror Harats, Israeli I.D No. (the “Executive”). The Company and Executive shall be sometimes referred to each as a “Party” and collectively as the “Parties”).
ASSET PURCHASE AGREEMENT by and betweenAsset Purchase Agreement • March 14th, 2023 • Vascular Biogenics Ltd. • Pharmaceutical preparations
This ASSET PURCHASE AGREEMENT (this “Agreement”), dated as of February 15, 2023, by and between Vascular Biogenics Ltd. an Israeli company (“Seller”), with its registered offices at 8 Hasatat Street, Modi’in, Israel and Aleph Farms Ltd., an Israeli company (“Buyer”), with its registered offices at 1 Haim Holtzman Street Rehovot 7670401, Israel. The Seller and the Buyer may be individually referred to as a “Party” and collectively as the “Parties”.
RESTATED CONSULTING AND SERVICES AGREEMENTConsulting and Services Agreement • March 14th, 2023 • Vascular Biogenics Ltd. • Pharmaceutical preparations
THIS RESTATED CONSULTING AND SERVICES AGREEMENT is made as of January 20, 2022 (the “Effective Date”), by and between Vascular Biogenetics Ltd, a company registered under the laws of the State of Israel (the “Company”) and Grand H Services Ltd. (the “Consultant”). The Company and the Consultant shall sometimes be referred to, each as a “Party” and collectively as the “Parties”.
